 |
Recombinant fusion protein of Mycobacterium bovis BCG Hsp65 and HPV16 E7 |
|---|---|
| Trade Name | |
| Orphan Indication | Recurrent respiratory papillomatosis |
| USA Market Approval | USA |
| USA Designation Date | 2001-03-19 00:00:00 |
| Sponsor | StressGen Biotechnologies, Inc. is now Nventa;Nventa Biopharmaceuticals Corporation, 6055 Lusk Boulevard;San Diego, California, 19426 |
